CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 14, 2022 · earnings

GALT earnings: a positive outcome, +5.6%

On November 14, 2022, Galectin Therapeutics Inc. reached its earnings. The result was a positive outcome, and the stock moved +5.6% in the window around the event. It had already run -24.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.22
1d before
$1.29
Event day
$1.24
1d after
$1.32
5d after

Pre-catalyst setup

-24.6%
30-day run-up
5401%
30-day volatility
1.5×
volume spike